Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 709 KB, PDF-dokument

  • Kazimierz Groen
  • Fredrik H. Schjesvold
  • Bronno Van Der Holt
  • Mark David Levin
  • Maarten R. Seefat
  • Markus Hansson
  • Maria B.L. Leys
  • Josien C. Regelink
  • Anders Waage
  • Damian Szatkowski
  • Per Axelsson
  • Trung Hieu Do
  • Asta Svirskaite
  • Ellen Van Der Spek
  • Einar Haukas
  • Dorota Knut-Bojanowska
  • Paula F. Ypma
  • Cecilie H. Blimark
  • Ulf Henrik Mellqvist
  • Niels W.C.J. Van De Donk
  • Pieter Sonneveld
  • Anja Klostergaard
  • Niels Abildgaard
  • Sonja Zweegman
OriginalsprogEngelsk
ArtikelnummerE940
TidsskriftHemaSphere
Vol/bind7
Udgave nummer9
Antal sider4
ISSN2572-9241
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This study had partial research funding from Takeda Pharmaceutical Company Limited.

ID: 397241610